Items where Author is "Hartung, H.-P."

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Date | Item Type | Refereed
Jump to: 2011
Number of items: 4.


Acaster, S. and Swinburn, P. and Wang, C. and Stemper, B. and Beckmann, K. and Knappertz, V. and Pohl, C. and Sandbrink, R. and Gondek, K. and Edan, G. and Kappos, L. and Freedman, M. and Hartung, H.-P. and Arnason, B. and Comi, G. and Filippi, M. and Jeffery, D. and O'Connor, P. and Cook, S. and Lloyd, A. J.. (2011) Can the functional assessment of multiple sclerosis adapt to changing needs? : a psychometric validation in patients with clinically isolated syndrome and early relapsing-remitting multiple sclerosis. Multiple Sclerosis Journal, 17 (12). pp. 1504-1513.

Waschbisch, A. and Sandbrink, R. and Hartung, H.-P. and Kappos, L. and Schwab, S. and Pohl, C. and Wiendl, H.. (2011) Evaluation of soluble HLA-G as a biomarker for multiple sclerosis. Neurology, Vol. 77, H. 6. pp. 596-598.

Filippi, M. and Rocca, M. A. and Camesasca, F. and Cook, S. and O'Connor, P. and Arnason, B. G. W. and Kappos, L. and Goodin, D. and Jeffery, D. and Hartung, H.-P. and Comi, G. and Wolinsky, J. S. and Bogumil, T. and Pohl, C. and Beckmann, K. and Sandbrink, R. and Croze, E. and Brown, C. and Desimone, T. M. and Arnold, D. L. and Cutter, G. and Knappertz, V.. (2011) Interferon β-1b and glatiramer acetate effects on permanent black hole evolution. Neurology, Vol. 76, H. 14. pp. 1222-1228.

Hartung, H.-P. and Freedman, M. S. and Polman, C. H. and Edan, G. and Kappos, L. and Miller, D. H. and Montalbán, X. and Barkhof, F. and Petkau, J. and White, R. and Sahajpal, V. and Knappertz, V. and Beckmann, K. and Lanius, V. and Sandbrink, R. and Pohl, C. and Benefit Study Group, . (2011) Interferon β-1b-neutralizing antibodies 5 years after clinically isolated syndrome. Neurology, Vol. 77, H. 9. pp. 835-843.

This list was generated on Tue Jun 22 23:37:35 2021 CEST.